Today: 1 May 2026
Swiss stocks hit 14,000 — Swiss Re, Holcim and UBS set up a busy week on SIX
1 March 2026
2 mins read

Swiss stocks hit 14,000 — Swiss Re, Holcim and UBS set up a busy week on SIX

Zurich, March 1, 2026, 08:30 CET — The market remains closed.

  • Swiss stocks open March trading with the SMI having closed out February above the 14,000-point mark.
  • Swiss Re’s results and its buyback announcement grabbed attention, while Holcim’s guidance and new UBS regulatory news also drew the spotlight.
  • Swiss central bank figures and inflation data take center stage for traders, with Friday’s U.S. jobs numbers up next.

The Swiss Market Index (SMI) wrapped up Friday at 14,014.30, climbing 0.72%. Swiss Re led the pack after posting results, while Holcim and UBS trailed. Defensive stalwarts Roche, Novartis and Nestlé moved higher, but Richemont slipped.

Swiss shares kick off March sitting at all-time highs, with investors now questioning how much more European equities can lean on so-called “safe” earnings. The focus has shifted to the next potential move in rates and credit — key factors that could pull banks and cyclicals back into the spotlight.

European stocks capped February at all-time highs, but banks took a hit, dragged down by concerns over possible credit losses and ripple effects from an AI-linked selloff. “Worries regarding potential irregularities in the mortgage space” are now setting investors on edge, said Ipek Ozkardeskaya, senior analyst at Swissquote Bank. Reuters

Late in the week on SIX, insurance and construction stocks grabbed the spotlight. Pharma and food heavyweights, meanwhile, gave the market a defensive tilt. That combination offers some shelter when risk appetite fades, but it also means the index ends up riding on just a handful of outperformers.

Swiss Re’s net profit jumped 47% in 2025, with the reinsurer unveiling an extra $1 billion share buyback that cut outstanding shares and pushed earnings per share higher. Shares responded, moving up on Friday. The company, however, pointed to underperformance in its life and health segment as elevated claims—especially in Australia—dragged results below targets.

Holcim cited a pickup in infrastructure outlays while projecting adjusted sales growth of 3% to 5% for 2026. The company’s quarterly results, though, took a hit from currency translation, weighing on figures in Swiss-franc terms. CEO Miljan Gutovic described himself as “very optimistic about 2026” and noted “good momentum” in major markets. Reuters

UBS finds itself back in the regulatory spotlight this week. According to the Neue Zuercher Zeitung, the board is pushing for CEO Sergio Ermotti to extend his tenure, hoping he’ll guide the bank through a brewing battle over new Swiss capital requirements. UBS could be forced to set aside as much as $24 billion more under the draft rules—a prospect that has investors uneasy, since higher capital buffers often mean less cash for buybacks and returns. A UBS spokesperson called timeline talk “premature to speculate.” Reuters

First up on the domestic docket, the Swiss National Bank will publish the detailed breakdown of its annual result. The SNB confirmed it will release the definitive report on March 2, while the full Annual Report is set for later in March.

The next data point: inflation. Switzerland’s Federal Statistical Office drops the February CPI numbers on March 4 at 8:30 a.m., and that readout could quickly alter rate forecasts — with the franc reacting, a major concern for exporters earning money outside the country.

Beyond Switzerland, markets exposed to rate moves are taking in fresh U.S. inflation data. January’s U.S. producer prices came in hotter than anticipated, according to Reuters on Friday, fueling the ongoing global debate between optimism for a “soft landing” and nagging inflation concerns. Reuters

The risks are clear enough. Fresh credit jitters? Banks usually feel it first. A stronger franc would trim reported revenue for the major Swiss players with global reach. Throw in new tariff worries or AI-disruption fears, and risk appetite might dry up—right as Swiss stocks hover close to their all-time peaks.

Friday brings the week’s most clear-cut catalyst: the U.S. jobs report for February drops at 8:30 a.m. ET, a data point with the power to jolt global rate forecasts and land immediately in Zurich as markets open.

Stock Market Today

  • Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK
    May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines and capital strategies amid challenging market conditions.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 12:18 AM EDT Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Sensex week ahead: AI fears, new GDP series and Holi break could swing Bombay Stock Exchange stocks
Previous Story

Sensex week ahead: AI fears, new GDP series and Holi break could swing Bombay Stock Exchange stocks

Gas Prices Forecast After Iran Attack: Will U.S. Gasoline Top $3 This Week?
Next Story

Gas Prices Forecast After Iran Attack: Will U.S. Gasoline Top $3 This Week?

Go toTop